Rosacea | COVID-19 Communication | Disease Risk | Coping | Coronavirus Vaccine

Discover how to manage rosacea, get tips to improve communication during COVID-19, learn about a potential coronavirus vaccine, and more.

Thursday, July 30, 2020   Relieving Rosacea Discover what you can do to manage the redness and other skin problems caused by the condition rosacea. (From NIH News in Health) Improving Communication During COVID-19 Cloth face coverings and distancing can cause communication challenges. Learn how to improve your conversations in the current pandemic. (From NIH's NIDCD) Genes and Disease Learn about polygenic risk scores—how your genetic data can help predict your risk of developing a disease. (NIH's NIGMS) Helping Children Cope with Crisis This activity book, geared towards African American families and communities, provides tools to help kids handle tragic events. (From NIH's NICHD) Experimental Coronavirus Vaccine Shows Promise Early results from the first COVID-19 vaccine tested in people showed that it triggered an immune response against the virus with no serious side effects. (From NIH Research Matters) This bimonthly newsletter contains resources and tips about healthy living and wellness from across NIH, the nation's medical research agency. To find more trusted health information from NIH, go to https://www.nih.gov/health-information. Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health. NIH…Turning Discovery Into Health®      This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612